Showing 10 of 10 recruiting trials for “undifferentiated-pleomorphic-sarcoma”
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
👨⚕️ Elise F Nassif, University of Texas MD Anderson Cancer Center LAO📍 1 site📅 Started Mar 2026View details ↗
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
👨⚕️ Candace L Haddox, Dana-Farber - Harvard Cancer Center LAO📍 16 sites📅 Started Feb 2024View details ↗
Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
👨⚕️ Alexander Shoushtari, MD, Memorial Sloan Kettering Cancer Center📍 2 sites📅 Started Nov 2022View details ↗
tTF-NGR Randomized Study - STS
👨⚕️ Christoph Schliemann, Prof. Dr., University Hospital Muenster (Department of Medicine A), Germany📍 9 sites📅 Started Oct 2021View details ↗
Neoadjuvant Irradiation of Extremity Soft Tissue Sarcoma With Ions
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
👨⚕️ Javier Martín-Broto, MD, Jiménez Díaz Foundation University Hospital📍 17 sites📅 Started Nov 2014View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →